Skip to content

Clinical trials

Endometrial Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Country / region: Germany Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20051
20071
20113
20121
20131
20151
20165
20174
20184
20192
20203
20216
20227
20238
20245
202511
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting29
Completed25
Active, not recruiting11
Unknown status2
Suspended1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Merck Sharp & Dohme LLC7
Novartis Pharmaceuticals4
Daiichi Sankyo3
Eli Lilly and Company3
AEterna Zentaris2
AGO Study Group2
BioNTech SE2
European Organisation for Research and Treatment of Cancer - EORTC2
Karyopharm Therapeutics Inc2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms70
Ovarian Neoplasms27
Uterine Cervical Neoplasms14
Colorectal Neoplasms12
Stomach Neoplasms11
Carcinoma, Non-Small-Cell Lung10
Neoplasms10
Pancreatic Neoplasms8
Esophageal Neoplasms7
Fallopian Tube Neoplasms7

Trials

Showing 51 to 70 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.